Is NWPHF or EQR a better dividend investment in 2026?

NWPHF currently yields 16.67% with a 5% 5-year dividend growth rate. EQR yields 4.73% with 5% growth. The better choice depends on your goal: NWPHF offers higher current income.

What is the dividend yield difference between NWPHF and EQR?

NWPHF has a forward dividend yield of 16.67% ($2.00/share annually). EQR yields 4.73% ($2.77/share annually). The yield gap is 11.94 percentage points.

Home › Compare › NWPHF vs EQR

NWPHF vs EQR: Dividend Comparison 2026

NWPHF yields 16.67% · EQR yields 4.73%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 NWPHF wins by $18.9K in total portfolio value

INVESTMENT

TIME HORIZON10 years

NWPHF

● Live price

16.67%

Share price

$12.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$59.4K

Annual income

$4,638.76

Full NWPHF calculator →

EQR

● Live price

4.73%

Share price

$58.58

Annual div

$2.77

5Y div CAGR

15.8%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$40.5K

Annual income

$3,819.61

Full EQR calculator →

Portfolio growth — NWPHF vs EQR

📍 NWPHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	NWPHF	EQR
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, NWPHF + EQR cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

NWPHF pays

EQR pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NWPHF

Annual income on $10K today (after 15% tax)

$1,416.67/yr

After 10yr DRIP, annual income (after tax)

$3,942.95/yr

EQR

Annual income on $10K today (after 15% tax)

$401.93/yr

After 10yr DRIP, annual income (after tax)

$3,246.67/yr

At 15% tax rate, NWPHF beats the other by $696.28/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NWPHF + EQR for your $10,000?

NWPHF: 50%EQR: 50%

100% EQR50/50100% NWPHF

Portfolio after 10yr

$49.9K

Annual income

$4,229.18/yr

Blended yield

8.47%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

NWPHF

No analyst data

Altman Z

4.4

Piotroski

5/9

EQR

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$70.35

+20.1% upside vs current

Range: $63.00 — $78.50

Altman Z

1.8

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NWPHF buys

EQR buys

No recent congressional trades found for NWPHF or EQR in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricNWPHFEQR

Forward yield	16.67% ✓	4.73%
Annual dividend / share	$2.00	$2.77 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	15.8% ✓
Portfolio after 10y	$59.4K ✓	$40.5K
Annual income after 10y	$4,638.76 ✓	$3,819.61
Total dividends collected	$30.6K ✓	$16.9K
Payment frequency	quarterly	quarterly
Sector	Stock	REIT

Year-by-year: NWPHF vs EQR ($10,000, DRIP)

Year	NWPHF Portfolio	NWPHF Income/yr	EQR Portfolio	EQR Income/yr	Gap
1← crossover	$12,367	$1,666.67	$11,248	$547.57	+$1.1K → NWPHF
2	$15,159	$1,926.27	$12,701	$666.53	+$2.5K → NWPHF
3	$18,426	$2,206.69	$14,405	$814.59	+$4.0K → NWPHF
4	$22,223	$2,506.90	$16,413	$999.84	+$5.8K → NWPHF
5	$26,604	$2,825.66	$18,795	$1,232.92	+$7.8K → NWPHF
6	$31,628	$3,161.43	$21,639	$1,527.95	+$10.0K → NWPHF
7	$37,355	$3,512.53	$25,057	$1,903.80	+$12.3K → NWPHF
8	$43,847	$3,877.10	$29,197	$2,385.87	+$14.7K → NWPHF
9	$51,169	$4,253.19	$34,250	$3,008.70	+$16.9K → NWPHF
10	$59,390	$4,638.76	$40,467	$3,819.61	+$18.9K → NWPHF

NWPHF vs EQR: Complete Analysis 2026

NWPHF — Stock

Newron Pharmaceuticals S.p.A., a clinical stage biopharmaceutical company, focuses on the research and development of therapies for the treatment of central and peripheral nervous system, and pain in Italy and the United States. The company offers Xadago (safinamide) for the treatment of Parkinson's disease, as well as develops Xadago for the treatment of levodopa induced dyskinesia. It also develops Evenamide for Schizophrenia and treatment resistant schizophrenia; and Ralfinamide for orphan indication in neuropathic pain. Newron Pharmaceuticals S.p.A. was founded in 1999 and is headquartered in Bresso, Italy.

Full NWPHF Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →

📬

Get this NWPHF vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NWPHF vs SCHD NWPHF vs JEPI NWPHF vs O NWPHF vs KO NWPHF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.